Orlistat Kidney-Injury Warning Now Covers OTC Alli
FDA revised OTC orlistat labeling to warn about rare acute kidney injury, urging symptom awareness, prompt discontinuation, medical evaluation, and careful medication reconciliation.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.